 | CGO | 表記: | sodium 3,3'-(1E,1'E)-biphenyl-4,4'-diylbis(diazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonate) | 組成式: | C32 H22 N6 Na2 O6 S2 | SMILES: | [Na+][O-]S(=O)(=O)c5cc(/N=N/c1ccc(cc1)c4ccc(/N=N/c3c(c2ccccc2c(c3)S(=O)(=O)[O-][Na+])N)cc4)c(N)c6c5cccc6 | InChi: | InChI=1S/C32H24N6O6S2.2Na/c33-31-25-7-3-1-5-23(25)29(45(39,40)41)17-27(31)37-35-21-13-9-19(10-14-21)20-11-15-22(16-12-20)36-38-28-18-30(46(42,43)44)24-6-2-4-8-26(24)32(28)34 | 別名: | congo red | 定義日: | 2011-04-21 | 最終更新日: | 2024-11-08 | 識別子(ID): | mu-{3,3'-[biphenyl-4,4'-diyldi(E)diazene-2,1-diyl]bis(4-aminonaphthalene-1-sulfonato-kappaO)(2-)}disodium |
|
 | YCL | 表記: | 2-{[(2S)-1-amino-5-{[(1Z)-2-chloroethanimidoyl]amino}-1-oxopentan-2-yl]carbamoyl}benzoic acid | 組成式: | C15 H19 Cl N4 O4 | SMILES: | ClCC(=[N@H])NCCCC(C(=O)N)NC(=O)c1ccccc1C(=O)O | InChi: | InChI=1S/C15H19ClN4O4/c16-8-12(17)19-7-3-6-11(13(18)21)20-14(22)9-4-1-2-5-10(9)15(23)24/h1-2,4-5,11H,3,6-8H2,(H2,17,19)(H2,18,21)(H,20,22)(H,23,24)/t11-/m0/s1 | 別名: | o-Cl-amidine | 定義日: | 2011-08-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | 2-{[(2S)-1-amino-5-{[(1Z)-2-chloroethanimidoyl]amino}-1-oxopentan-2-yl]carbamoyl}benzoic acid |
|
 | ZSN | 表記: | 1-(2-amino-2-oxoethyl)hydrazinecarboxylic acid | 組成式: | C3 H7 N3 O3 | SMILES: | O=C(N)CN(N)C(=O)O | InChi: | InChI=1S/C3H7N3O3/c4-2(7)1-6(5)3(8)9/h1,5H2,(H2,4,7)(H,8,9) | 別名: | Aza-asparagine | 定義日: | 2012-06-01 | 最終更新日: | 2024-09-27 | 公開日: | 2013-06-26 | 識別子(ID): | 1-(2-amino-2-oxoethyl)hydrazinecarboxylic acid |
|
 | XZA | 表記: | diazanecarboxylic acid | 組成式: | C H4 N2 O2 | SMILES: | NNC(O)=O | InChi: | InChI=1S/CH4N2O2/c2-3-1(4)5/h3H,2H2,(H,4,5) | 定義日: | 2016-06-03 | 最終更新日: | 2024-09-27 | 公開日: | 2017-06-28 | 識別子(ID): | diazanecarboxylic acid |
|
 | ZT1 | 表記: | N~6~-[(1-methyl-1H-imidazol-5-yl)methyl]-N~6~-propan-2-yl-L-lysine | 組成式: | C14 H26 N4 O2 | SMILES: | Cn1cncc1CN(CCCCC(N)C(=O)O)C(C)C | InChi: | InChI=1S/C14H26N4O2/c1-11(2)18(9-12-8-16-10-17(12)3)7-5-4-6-13(15)14(19)20/h8,10-11,13H,4-7,9,15H2,1-3H3,(H,19,20)/t13-/m0/s1 | 定義日: | 2021-05-28 | 最終更新日: | 2024-09-27 | 公開日: | 2021-07-21 | 識別子(ID): | N~6~-[(1-methyl-1H-imidazol-5-yl)methyl]-N~6~-propan-2-yl-L-lysine |
|
 | YFF | 表記: | 2-{[(2S)-1-amino-5-{[(1Z)-2-fluoroethanimidoyl]amino}-1-oxopentan-2-yl]carbamoyl}benzoic acid | 組成式: | C15 H19 F N4 O4 | SMILES: | FCC(=[N@H])NCCCC(C(=O)N)NC(=O)c1ccccc1C(=O)O | InChi: | InChI=1S/C15H19FN4O4/c16-8-12(17)19-7-3-6-11(13(18)21)20-14(22)9-4-1-2-5-10(9)15(23)24/h1-2,4-5,11H,3,6-8H2,(H2,17,19)(H2,18,21)(H,20,22)(H,23,24)/t11-/m0/s1 | 別名: | o-F-amidine | 定義日: | 2011-08-16 | 最終更新日: | 2024-09-27 | 識別子(ID): | 2-{[(2S)-1-amino-5-{[(1Z)-2-fluoroethanimidoyl]amino}-1-oxopentan-2-yl]carbamoyl}benzoic acid |
|
 | Y1V | 表記: | (4R)-5-amino-L-leucine | 組成式: | C6 H14 N2 O2 | SMILES: | C(O)(=O)C(CC(CN)C)N | InChi: | InChI=1S/C6H14N2O2/c1-4(3-7)2-5(8)6(9)10/h4-5H,2-3,7-8H2,1H3,(H,9,10)/t4-,5+/m1/s1 | 定義日: | 2021-01-27 | 最終更新日: | 2024-09-27 | 公開日: | 2021-08-11 | 識別子(ID): | (4R)-5-amino-L-leucine |
|
 | YUN | 表記: | N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | 組成式: | C17 H15 Br N4 O | SMILES: | Brc1cccc(c1)Nc3ncnc2c3cc(cc2)NC(=O)CC | InChi: | InChI=1S/C17H15BrN4O/c1-2-16(23)21-13-6-7-15-14(9-13)17(20-10-19-15)22-12-5-3-4-11(18)8-12/h3-10H,2H2,1H3,(H,21,23)(H,19,20,22) | 定義日: | 2013-08-02 | 最終更新日: | 2024-09-27 | 公開日: | 2013-09-11 | 識別子(ID): | N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide |
|
 | XD2 | 表記: | (2R)-2-[(1R)-1-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-2-oxoethyl]-5-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | 組成式: | C18 H20 N6 O5 S2 | SMILES: | O=CC(NC(=O)C(O)c1ccccc1)C2SCC(=C(N2)C(=O)O)CSc3nnnn3C | InChi: | InChI=1S/C18H20N6O5S2/c1-24-18(21-22-23-24)31-9-11-8-30-16(20-13(11)17(28)29)12(7-25)19-15(27)14(26)10-5-3-2-4-6-10/h2-7,12,14,16,20,26H,8-9H2,1H3,(H,19,27)(H,28,29)/t12-,14-,16-/m1/s1 | 別名: | Cefamandole, bound form | 定義日: | 2010-06-09 | 最終更新日: | 2024-09-27 | 識別子(ID): | (2R)-2-[(1R)-1-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-2-oxoethyl]-5-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | MH0 | 表記: | Mesoheme | 組成式: | C34 H36 Fe N4 O4 | SMILES: | O=C(O)CCC1=C(C2=CC=6C(=C(C5=CC=4C(=C(C3=CC=7C(=C(C8=CC1=N2[Fe](N3=4)(N5=6)N=78)CCC(=O)O)C)C)CC)C)CC)C | InChi: | InChI=1S/C34H36N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25 | 定義日: | 2013-05-03 | 最終更新日: | 2024-09-27 | 公開日: | 2013-07-03 | 識別子(ID): | [3,3'-(7,12-diethyl-3,8,13,17-tetramethylporphine-2,18-diyl-kappa~4~N~21~,N~22~,N~23~,N~24~)dipropanoic acid]iron |
|
 | MHZ | 表記: | 5'-DEOXY-5'-[(3-HYDRAZINOPROPYL)METHYLAMINO]ADENOSINE | 組成式: | C14 H24 N8 O3 | SMILES: | n2c1c(ncnc1n(c2)C3OC(C(O)C3O)CN(CCCNN)C)N | InChi: | InChI=1S/C14H24N8O3/c1-21(4-2-3-20-16)5-8-10(23)11(24)14(25-8)22-7-19-9-12(15)17-6-18-13(9)22/h6-8,10-11,14,20,23-24H,2-5,16H2,1H3,(H2,15,17,18)/t8-,10-,11-,14-/m1/s1 | 定義日: | 2001-03-13 | 最終更新日: | 2024-09-27 | 識別子(ID): | 5'-deoxy-5'-[(3-hydrazinopropyl)(methyl)amino]adenosine |
|
 | NWJ | 表記: | 2-amino-6-(3-formylphenyl)-4-(pyrrolidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile | 組成式: | C18 H16 N6 O | SMILES: | O=Cc1cccc(c1)c3c(C#N)c2c(nc(nc2n3)N)N4CCCC4 | InChi: | InChI=1S/C18H16N6O/c19-9-13-14-16(21-15(13)12-5-3-4-11(8-12)10-25)22-18(20)23-17(14)24-6-1-2-7-24/h3-5,8,10H,1-2,6-7H2,(H3,20,21,22,23) | 定義日: | 2014-01-15 | 最終更新日: | 2024-09-27 | 公開日: | 2015-01-21 | 識別子(ID): | 2-amino-6-(3-formylphenyl)-4-(pyrrolidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile |
|
 | HD0 | 表記: | (2S)-2-[(3S)-3-amino-2,5-dioxopyrrolidin-1-yl]-3-(1H-imidazol-5-yl)propanoic acid | 組成式: | C10 H12 N4 O4 | SMILES: | O=C(O)C(N1C(=O)CC(C1=O)N)Cc2ncnc2 | InChi: | InChI=1S/C10H12N4O4/c11-6-2-8(15)14(9(6)16)7(10(17)18)1-5-3-12-4-13-5/h3-4,6-7H,1-2,11H2,(H,12,13)(H,17,18)/t6-,7-/m0/s1 | 定義日: | 2010-11-01 | 最終更新日: | 2024-09-27 | 公開日: | 2022-06-29 | 識別子(ID): | (2S)-2-[(3S)-3-amino-2,5-dioxopyrrolidin-1-yl]-3-(1H-imidazol-5-yl)propanoic acid |
|
 | HDE | 表記: | CIS-HEME D HYDROXYCHLORIN GAMMA-SPIROLACTONE 17R, 18S | 組成式: | C34 H38 Fe N4 O5 | SMILES: | O=C(O)CCc9c(c4n6c9C=C8N5C(=Cc1c(c(c3n1[Fe]56n2c(c(c(c2C3)C)CC)C4)CC)C)C(O)(C)C87OC(=O)CC7)C | InChi: | InChI=1S/C34H38N4O5.Fe/c1-7-20-17(3)23-13-27-21(8-2)18(4)25(37-27)15-29-33(6,42)34(12-11-32(41)43-34)30(38-29)16-28-22(9-10-31(39)40)19(5)24(36-28)14-26(20)35-23 | 定義日: | 2010-10-20 | 最終更新日: | 2024-09-27 | 識別子(ID): | {3-[(2R,5'S)-10',15'-diethyl-5'-hydroxy-5',9',14',19'-tetramethyl-5-oxo-4,5-dihydro-3H-spiro[furan-2,4'-[21,22,23,24]tetraazapentacyclo[16.2.1.1~3,6~.1~8,11~.1~13,16~]tetracosa[1(20),2,6,8,10,13,15,18]octaen]-20'-yl-kappa~4~N~21'~,N~22'~,N~23'~,N~24'~]propanoato(4-)}iron |
|
 | HEM | 表記: | PROTOPORPHYRIN IX CONTAINING FE | 組成式: | C34 H32 Fe N4 O4 | SMILES: | C=1c3c(c(c4C=C5C(=C(C=6C=C7C(=C(C8=CC=2C(=C(C=1N=2[Fe](n34)(N5=6)N78)CCC(=O)O)C)C=C)C)C=C)C)C)CCC(=O)O | InChi: | InChI=1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25 | 別名: | HEME | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | 3-[(5Z,10Z,14Z,19Z)-18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-21,23-dihydroporphyrin-2-yl]propanoic acid |
|
 | HSE | 表記: | L-HOMOSERINE | 組成式: | C4 H9 N O3 | SMILES: | O=C(O)C(N)CCO | InChi: | InChI=1S/C4H9NO3/c5-3(1-2-6)4(7)8/h3,6H,1-2,5H2,(H,7,8)/t3-/m0/s1 | 定義日: | 2000-02-02 | 最終更新日: | 2024-09-27 | 識別子(ID): | L-homoserine |
|
 | P2Q | 表記: | 2-hydroxy-5-{[(1S,2E)-1-formyl-4-phenoxybut-2-en-1yl]amino}-L-tyrosine | 組成式: | C20 H22 N2 O6 | SMILES: | N[CH](Cc1cc(N[CH](C=O)C=CCOc2ccccc2)c(O)cc1O)C(O)=O | InChi: | InChI=1S/C20H22N2O6/c21-16(20(26)27)9-13-10-17(19(25)11-18(13)24)22-14(12-23)5-4-8-28-15-6-2-1-3-7-15/h1-7,10-12,14,16,22,24-25H,8-9,21H2,(H,26,27)/b5-4+/t14-,16-/m0/s1 | 別名: | 3-{[(1S,2E)-1-formyl-4-phenoxybut-2-en-1-yl]amino}-6-hydroxy-L-tyrosine | 定義日: | 2009-11-10 | 最終更新日: | 2024-09-27 | 識別子(ID): | (2S)-2-azanyl-3-[2,4-dihydroxy-5-[[(E,2S)-1-oxo-5-phenoxy-pent-3-en-2-yl]amino]phenyl]propanoic acid |
|
 | P2Y | 表記: | (2S)-PYRROLIDIN-2-YLMETHYLAMINE | 組成式: | C5 H12 N2 | SMILES: | NCC1NCCC1 | InChi: | InChI=1S/C5H12N2/c6-4-5-2-1-3-7-5/h5,7H,1-4,6H2/t5-/m0/s1 | 定義日: | 2003-03-20 | 最終更新日: | 2024-09-27 | 識別子(ID): | 1-[(2S)-pyrrolidin-2-yl]methanamine |
|
 | PEB | 表記: | PHYCOERYTHROBILIN | 組成式: | C33 H40 N4 O6 | SMILES: | CC[CH]1[CH](C)C(=O)NC1=CC2=NC(=Cc3[nH]c(C[CH]4NC(=O)C(=C4C)C=C)c(C)c3CCC(O)=O)C(=C2C)CCC(O)=O | InChi: | InChI=1S/C33H40N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h8,14-15,19-20,26,34H,2,7,9-13H2,1,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b27-14-,29-15-/t19-,20-,26-/m1/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | 3-[2-[(Z)-[3-(2-carboxyethyl)-5-[(Z)-[(3R,4R)-3-ethyl-4-methyl-5-oxo-pyrrolidin-2-ylidene]methyl]-4-methyl-pyrrol-2-ylidene]methyl]-5-[[(2R)-4-ethenyl-3-methyl-5-oxo-1,2-dihydropyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid |
|
 | PUB | 表記: | PHYCOUROBILIN | 組成式: | C33 H42 N4 O6 | SMILES: | CCC1=C(C)C(=O)N[CH]1Cc2[nH]c(C=C3N=C(C[CH]4NC(=O)C(=C4C)CC)C(=C3CCC(O)=O)C)c(CCC(O)=O)c2C | InChi: | InChI=1S/C33H42N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h15,26-27,35H,7-14H2,1-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b28-15-/t26-,27+/m1/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | 3-[(2Z)-2-[[3-(2-carboxyethyl)-5-[[(2S)-3-ethyl-4-methyl-5-oxo-1,2-dihydropyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[[(2R)-4-ethyl-3-methyl-5-oxo-1,2-dihydropyrrol-2-yl]methyl]-4-methyl-pyrrol-3-yl]propanoic acid |
|
 | KY7 | 表記: | {(4Z)-2-[(1S)-1-amino-2-sulfanylethyl]-4-[(4-hydroxy-3-nitrophenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | 組成式: | C14 H14 N4 O6 S | SMILES: | NC(CS)C1=N/C(C(N1CC(=O)O)=O)=Cc2cc(c(cc2)O)[N+](=O)[O-] | InChi: | InChI=1S/C14H14N4O6S/c15-8(6-25)13-16-9(14(22)17(13)5-12(20)21)3-7-1-2-11(19)10(4-7)18(23)24/h1-4,8,19,25H,5-6,15H2,(H,20,21)/b9-3-/t8-/m1/s1 | 別名: | CHROMOPHORE (CYS-TYR-GLY)-3-NO2 | 定義日: | 2019-01-23 | 最終更新日: | 2024-09-27 | 公開日: | 2019-06-12 | 識別子(ID): | {(4Z)-2-[(1S)-1-amino-2-sulfanylethyl]-4-[(4-hydroxy-3-nitrophenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
 | QQ8 | 表記: | (4~{S})-4-azanyl-5-formamido-pentanamide | 組成式: | C6 H13 N3 O3 | SMILES: | N[CH](CCC(N)=O)CNC(O)=O | InChi: | InChI=1S/C6H13N3O3/c7-4(1-2-5(8)10)3-9-6(11)12/h4,9H,1-3,7H2,(H2,8,10)(H,11,12)/t4-/m0/s1 | 定義日: | 2020-07-23 | 最終更新日: | 2024-09-27 | 公開日: | 2021-06-09 | 識別子(ID): | [(2~{S})-2,5-bis(azanyl)-5-oxidanylidene-pentyl]carbamic acid |
|
 | QQB | 表記: | ~{N}-[(2~{S})-2-azanyl-3-naphthalen-1-yl-propyl]methanamide | 組成式: | C14 H16 N2 O2 | SMILES: | N[CH](CNC(O)=O)Cc1cccc2ccccc12 | InChi: | InChI=1S/C14H16N2O2/c15-12(9-16-14(17)18)8-11-6-3-5-10-4-1-2-7-13(10)11/h1-7,12,16H,8-9,15H2,(H,17,18)/t12-/m0/s1 | 定義日: | 2020-07-23 | 最終更新日: | 2024-09-27 | 公開日: | 2021-06-09 | 識別子(ID): | [(2~{S})-2-azanyl-3-naphthalen-1-yl-propyl]carbamic acid |
|
 | 621 | 表記: | N-acetylglycyl-N-[(3S)-1-hydroxy-5-methyl-2-oxohexan-3-yl]-L-serinamide | 組成式: | C14 H25 N3 O6 | SMILES: | O=C(NC(C(=O)CO)CC(C)C)C(NC(=O)CNC(=O)C)CO | InChi: | InChI=1S/C14H25N3O6/c1-8(2)4-10(12(21)7-19)17-14(23)11(6-18)16-13(22)5-15-9(3)20/h8,10-11,18-19H,4-7H2,1-3H3,(H,15,20)(H,16,22)(H,17,23)/t10-,11-/m0/s1 | 定義日: | 2010-12-02 | 最終更新日: | 2024-09-27 | 識別子(ID): | N-acetylglycyl-N-[(3S)-1-hydroxy-5-methyl-2-oxohexan-3-yl]-L-serinamide |
|
 | S99 | 表記: | 7-phenyl-1-(4-pyridin-2-yl-1,3-oxazol-2-yl)heptane-1,1-diol | 組成式: | C21 H24 N2 O3 | SMILES: | n3c(c1nc(oc1)C(O)(O)CCCCCCc2ccccc2)cccc3 | InChi: | InChI=1S/C21H24N2O3/c24-21(25,14-8-2-1-4-10-17-11-5-3-6-12-17)20-23-19(16-26-20)18-13-7-9-15-22-18/h3,5-7,9,11-13,15-16,24-25H,1-2,4,8,10,14H2 | 定義日: | 2009-05-19 | 最終更新日: | 2024-09-27 | 識別子(ID): | 7-phenyl-1-(4-pyridin-2-yl-1,3-oxazol-2-yl)heptane-1,1-diol |
|